Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice. Mar 2010 - :1090-2163 [PMID:20236626] [Saha A] [Chatterjee SK]
Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. Apr 2009 - Cell. Immunol.; 257(1-2):1090-2163 [PMID:19306994] [Delirezh N] [Moazzeni SM] [Shokri F] [Shokrgozar MA] [Atri M] [Kokhaei P]
Tumor vaccines for breast cancer. Apr 2009 - Cancer Invest.; 27(4):1532-4192 [PMID:19358018] [Anderson KS]
Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study. Apr 2009 - Cancer Immunol. Immunother.; 58(6):1432-0851 [PMID:18998129] [Schuetz F] [Ehlert K] [Ge Y] [Schneeweiss A] [Rom J] [Inzkirweli N] [Sohn C] [Schirrmacher V] [Beckhove P]
Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice. Sep 2008 - Surg. Today; 38(10):0941-1291 [PMID:18820866] [Kanaya Y] [Doihara H] [Shiroma K] [Ogasawara Y] [Date H]
Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy. Aug 2008 - J. Immunol.; 181(5):1550-6606 [PMID:18714045] [Zhang M] [Berndt BE] [Chen JJ] [Kao JY]
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2. Aug 2008 - Vaccine; 26(36):0264-410X [PMID:18616968] [Svane IM] [Pedersen AE] [Nikolajsen K] [Zocca MB]
[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells] Jul 2008 - Zhonghua Zhong Liu Za Zhi; 30(2):0253-3766 [PMID:18646691] [Shi YJ] [Ren HY] [Cen XN] [Dong YJ] [Ma MX] [Zhao YL] [Zhu Y] [Yu JR]
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells. Jun 2008 - J. Immunol.; 181(1):0022-1767 [PMID:18566447] [Vasir B] [Wu Z] [Crawford K] [Rosenblatt J] [Zarwan C] [Bissonnette A] [Kufe D] [Avigan D]
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. May 2008 - Cancer Res.; 68(10):1538-7445 [PMID:18483270] [Wei H] [Wang H] [Lu B] [Li B] [Hou S] [Qian W] [Fan K] [Dai J] [Zhao J] [Guo Y]
Reengineering dendritic cell-based anti-cancer vaccines. Mar 2008 - Immunol. Rev.; 222:1600-065X [PMID:18364007] [Koski GK] [Cohen PA] [Roses RE] [Xu S] [Czerniecki BJ]
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2. Feb 2008 - Cancer Immunol. Immunother.; 57(5):0340-7004 [PMID:17786440] [Nabekura T] [Nagasawa T] [Nakauchi H] [Onodera M]
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge. Feb 2008 - Br. J. Cancer; 98(4):0007-0920 [PMID:18253127] [Grimshaw MJ] [Papazisis K] [Picco G] [Bohnenkamp H] [Noll T] [Taylor-Papadimitriou J] [Burchell J]
The importance of schedule in whole body thermochemotherapy. Feb 2008 - Int J Hyperthermia; 24(2):0265-6736 [PMID:18283593] [Bull JM] [Strebel FR] [Jenkins GN] [Deng W] [Rowe RW]
Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines. Nov 2007 - Int. J. Oncol.; 31(6):1019-6439 [PMID:17982663] [Serhal K] [Baillou C] [Ghinea N] [Fontanges P] [Dupuy FP] [Lemoine FM] [Lacave R]
